Senior Quality/Regulatory Biostatistician
iRhythm TechnologiesFull Time
Senior (5 to 8 years), Expert & Leadership (9+ years)
A Master's or PhD in Statistics, Biostatistics, or a related field is required, though a Bachelor's degree with substantial biostatistics experience will be considered. Candidates must have at least 2 years of biostatistics experience, preferably in clinical trials, and proficiency in statistical software like SAS, R, or Python. Experience in life sciences, regulatory environments, and knowledge of 21 CFR Part 11 and GxP are highly preferred. Strong statistical knowledge, including survival analysis, mixed models, and longitudinal data analysis, is essential, along with excellent problem-solving abilities, attention to detail, and strong written and verbal communication skills.
The Biostatistician will provide statistical expertise in the design and analysis of clinical trials, develop and author Statistical Analysis Plans (SAPs), and contribute to study randomization. They will review clinical trial protocols, analyze clinical trial data using advanced statistical techniques, and collaborate with Statistical Programmers to validate data sets and statistical outputs. Responsibilities also include reviewing and signing off on study documents and data management deliverables, providing programming support for analyses, staying current with regulatory guidelines, and representing biostatistics on project teams.
Provides interactive response technology for clinical trials
Endpoint Clinical provides interactive response technology (IRT) systems designed for clinical trials. Their systems assist with various trial processes such as managing drug supplies, randomizing patients, and scheduling visits. These systems are user-friendly and cater to clients in the life sciences sector, including pharmaceutical and biotechnology companies. Endpoint Clinical differentiates itself by focusing on ease of use and integration with other clinical trial management systems, ensuring that clients can streamline their processes and maintain regulatory compliance. The company's goal is to enhance the efficiency and transparency of clinical trials, allowing sponsors to conduct their research more effectively.